Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment-Reference-Cited by-同舟云学术

Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

Published:2021-01-01 Issue:1 Volume:13 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

White Ian¹,Tamot Ninkka¹^ORCID,Doddareddy Rajitha¹,Ho Jason¹,Jiao Qun¹,Harvilla Paul B.¹,Yang Tong-Yuan¹,Geist Brian¹,Borrok M. Jack¹,Truppo Matthew D.²,Ganesan Rajkumar³^ORCID,Chowdhury Partha¹^ORCID,Zwolak Adam¹^ORCID

Affiliation:

1. Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA

2. Active Pharmaceutical Ingredient Development, Janssen R&D LLC, Spring House, PA, USA

3. Biologics Discovery, Alector, Inc., South San Francisco, CA, USA

Funder

Janssen Research & Development

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2021.1987180

Reference62 articles.

1. An interactive web-based dashboard to track COVID-19 in real time

2. Novel therapeutic approaches for treatment of COVID-19

3. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine

4. Administration USFaD. CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19. September 25, 2021. https://wwwfdagov/drugs/coronavirus-covid-19-drugs/cder-scientific-review-documents-supporting-emergency-use-authorizations-drug-and-biological

5. IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assays

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic analysis of ternary and binary binding modes of the bispecific antibody emicizumab;mAbs;2022-12-01

2. Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants;BioDrugs;2022-04-27

3. Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation;Frontiers in Medical Technology;2022-03-28